References 1 Gardner WN, Meah M. Bass C. Controlled study of respiratory responses during prolonged measurement in pateints with chronic hyperventilation. Lancet 1986;ii: 826-30 2 Bass C, Gardner WN. Respiratory and psychiatric abnormalities in chronic symptomatic hyperventilation. Br Med J 1985; 290:1387- investigation. This was the situation deplored 50 years ago by Kerr et al.3:' They are often shunted from one physician to another, and the sins of commission inflicted upon them fill many black pages in our book of achievement'. My laboratory was specifically orientated to the evaluation of airway obstruction and, working in close collaboration with the cardiac unit, we were well aware of the coexistence of hyperventilation with myocardial disease" as well as asthma. This is not the place to argue the flaws in the paper by Dent et al. purporting to show that the HVS did not exist. After further experience these workers admitted the diagnosis in 20% of their cases", Bass et al. insist that HV must be defined by an arbitrary value for Pco.. They ignore the fact that it is also defined by respiratory alkalosis. The latter occurs, even within the normal reference range for Pco., whenever this is temporarily displaced below the prevailing level, leaving an excess of bicarbonate ion -by definition, respiratory alkalosis. Given the views in their letter, it is surprising to find the following statement from the same team": 'The hyperventilation syndrome is probably one of the most common psychophysiological reactions encountered by physicians ... Despite its prevalence, hyperventilation is seldom recognized ... Patients are often subjected to years of expensive and often invasive investigations ... before the true nature of their illness is recognized'; and 'Spot measurement of arterial or end-tidal Peo 2 shows hypocapnia (less than 30 mmHg) in only a minority of cases'. Papers such as theirs serve only to perpetuate failure to recognize the syndrome. Cardiology in Practice, January 1984; 27-34 Beta-blockers in myocardial infarction Sir, I was interested to read Dr Greenbaum's editorial (July JRSM, p 402) on the routine use of betablockers in patients who have survived myocardial infarction (MI). There have been 28 studies using intravenous beta-blockade started within 24 hours of the onset of the first symptoms of acute MI. An overview, or meta-analysis of the results from these 28 trials reveals that after only one week of treatment the mortality is reduced by about 14% 1.2 •.If this find. ing is extrapolated to the 100 360 patients adniitted to hospital in England and Wales in 1981with acute Ml, some 3500 lives might be saved, with the hospital more tality dropping from 25% to under 22%3. However, up to two-thirds of all patients admitted will either
